Torsdag 18 December | 23:50:20 Europe / Stockholm
Svenska | English

BioStock

Pila Pharmas new scientific adviser comments on the obesity development
2025-12-18 14:15:00

Pila Pharma recently strengthened its scientific advisory board with a significant addition: Professor Thomas Lutz, a renowned expert in metabolic research and the pancreatic hormone amylin. As the company approaches key preclinical proof-of-concept results for its candidate XEN-D0501, BioStock reached out to Professor Lutz to discuss his decision to join, his view on the obesity market, and the potential of Pila Pharma's novel approach.

Read the full article at biostock.se:
https://biostock.se/en/2025/12/pila-pharmas-nya-vetenskaplige-radgivare-kommenterar-utvecklingen-inom-fetmaomradet/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter 
Follow BioStock on social media: LinkedIn and Facebook!  
 
About BioStock 
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital. 

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden